ID   Mela16
AC   CVCL_VP47
SY   MELA16
DR   cancercelllines; CVCL_VP47
DR   Wikidata; Q95988716
WW   https://www.criver.com/sites/default/files/resources/CharacterizationofNovelPatient-DerivedMelanomaXenograftsandCellLinesinResponsetoTargetedTherapies.pdf
CC   Doubling time: 33 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow, Laura A.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 13,14
ST   D16S539: 12
ST   D18S51: 14
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 12,15
ST   FGA: 21,22
ST   TH01: 8,9.3
ST   TPOX: 11,12
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//